Clinical Developments in Allergen Immunotherapy

Allergen Immunotherapy (AI) Overview

AI Overview (cont)

Recent Developments in AI

Cox et al Study of a 5-grass Pollen Sublingual Tablet

Primary Efficacy Data From 3 Studies of Grass Sublingual Tablet

Blaiss et al Study of Grass Pollen Sublingual Tablet

Blaiss et al Study of Grass Pollen Sublingual Tablet (cont)

Primary Efficacy Data From 2 Studies of Ragweed Sublingual

Tablet

Ragweed Sublingual Tablet for AI

Reduction in TCS During Peak Ragweed Season

Where Sublingual AI Stands in the US

A Study of Sublingual Liquid AI

Results

Safety of Subcutaneous AI

Safety of Sublingual AI (cont)

Safety of Sublingual AI (cont)

Safety of Sublingual AI (cont)

Studies Directly Comparing SLIT and SCIT Adherencea

Monophosphoryl Lipid A (MPLA)

MPLA (cont)

Ultrashort-specific Immunotherapy for Seasonal Allergic Rhinoconjunctivitis Caused

by Grass Pollen

Ultrashort-specific Immunotherapy (cont)

Abbreviations

References

References (cont)

References (cont)

References (cont)